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Abstract
Speciﬁc functional properties of dendritic cells (DCs) have been suspected as being responsible for the impaired speciﬁc
immune responses observed in human neonates. To analyze stimulatory requirements for the critical transition from
immature, antigen-processing DCs to mature, antigen-presenting DCs, we investigated the effect of different
proinﬂammatory mediators and antigens on phenotype and cytokine secretion of human neonatal DCs derived from
hematopoietic progenitor cells (HPCs). Whereas single proinﬂammatory mediators were unable to induce the maturation of
neonatal DCs, various combinations of IFNg, CD40L, TNFa, LPS and antigens, induced the maturation of neonatal DCs
documented by up-regulation of HLA-DR, CD83 and CD86. Combinations of proinﬂammatory mediators also increased
cytokine secretion by neonatal DCs. Especially combined stimulation with LPS and IFNg proved to be very efﬁcient in
inducing maturation and cytokine synthesis of neonatal DCs. In conclusion, neonatal DCs can be stimulated to express
maturation as well as costimulatory surface molecules. However, induction of maturation requires combined stimulation with
multiple proinﬂammatory signals.
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Introduction
Clinical experience shows that early infancy is
associated with an increased susceptibility to
infectious diseases as well as impaired responses to
vaccines. These ﬁndings have been attributed to the
immaturity of the neonatal immune system. The
developmental status of the speciﬁc immune system
in human newborns entails signiﬁcant differences to
the immunological capacity seen in adolescents or
adults. While some characteristics of neonatal T cells
contribute to the immunological immaturity
(Adkins et al. 2001), it has been proposed that an
impaired function of antigen-presenting cells might
also play an important role (Trivedi et al. 1997).
Data from murine models showed an impaired
ability of neonatal DCs to activate naı ¨ve T
lymphocytes in comparison to DCs from adult
animals (Muthukkumar et al. 2000). In contrast,
conﬂicting data has been published concerning the
functional capacity of human neonatal DCs. While
some authors report that DCs generated from
human newborns are potent stimulators of allogen-
ous T cells (Sorg et al. 1998), others observe an
impaired function of neonatal DCs compared to
adult DCs (Hunt et al. 1994). Only the inability of
neonatal DCs to deliver the signals needed for
the polarization of immune responses towards a
TH1-type has been reported consistently (Taylor
and Bryson 1985, Trivedi et al. 1997, Delespesse
et al. 1998).
We investigated the effect of different proinﬂamma-
tory mediators as well as viral and bacterial antigens
on maturation and secretory function of neonatal
hematopoietic progenitor cell (HPC)-derived DCs.
The maturational status of DCs was determined by
the expression pattern of surface molecules and the
production of cytokines.
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synthesize equivalent amounts of IL-12p40 in
response to microbial stimuli, secretion of IL-12p70
by neonatal APCs is generally thought to be defective
(Lee et al. 1996, Joyneret al. 2000, Gorielyet al. 2001,
Tonon et al. 2002, Langrish et al. 2002). Since IL-12
plays a crucial role for the polarization of immune
responses towards a TH1-type, we studied the
production of both the IL-12p40 sub-unit and the
bioactive IL-12p70 heterodimer by neonatal DCs
after stimulation with proinﬂammatory mediators.
Materials and methods
Isolation and culture of cord blood CD34
þ HPCs
Umbilical cord blood samples were collected accord-
ing to institutional guidelines by venipuncture of
placental blood from healthy full-term infants born by
cesarean section. The heparinized blood was immedi-
ately centrifuged to obtain autologous plasma and
then diluted 1:1 with RPMI 1640 (Gibco, Eggenstein,
Germany). Plasma samples were heat inactivated at
568Cf o r3 0 m i na n ds t o r e da t2808C. The
mononuclear cell fraction (CBMCs) was obtained by
Ficoll-Hypaque (Biochrom seromed, Berlin,
Germany) density centrifugation. CBMCs were
washed and magnetically labeled for CD34 expression
with anti-CD34 paramagnetic Microbeads (Miltenyi-
Biotec, Bergisch-Gladbach, Germany). Labeled cells
were enriched on VS þ Separation Columnse in the
magnetic ﬁeld of a VarioMACSe (both Miltenyi
Biotec, Bergisch-Gladbach, Germany) according to
the manufacturer’s instructions. For increased purity
of enriched CD34
þ HPCs, the separation step of each
sample was performed twice.
Enriched CD34
þ HPCs (1 £ 10
5 cells/well) were
ampliﬁed in culture medium (RPMI 1640; Gibco,
Eggenstein, Germany) containing 2mM L-glutamine
(Gibco, Eggenstein, Germany), 1mM sodium pyr-
uvate, 100IU/ml penicillin, 100mg/ml streptomycin,
1 £ MEM amino acids (Biochrom, Berlin, Germany),
0,05mM b-mercaptoethanol (Sigma-Aldrich, Tauf-
kirchen, Germany) with 10% AB-Serum (PAN
Biotech, Aidenbach, Germany), 50ng/ml rhFLT3-
Ligand, 40ng/ml rhSCF and 20ng/ml rhTPO (Tebu,
Offenbach, Germany) in 24-well ﬂat-bottom plates
(Nunc, Wiesbaden, Germany). Cells were incubated
at 378C in a humidiﬁed atmosphere containing 5%
CO2. Medium and cytokines were replaced every 3
days until the start of stimulation assays, which was
deﬁned as day 0.
Generation of dendritic cells (DCs) from HPCs
Differentiation into immature DCs was induced by
culturing ampliﬁed HPCs (5 £ 10
5 cells/well) with
culture medium containing 10% autologous plasma,
100ng/ml rhGM-CSF and 20ng/ml rhIL-4 in 24-well
ﬂat-bottom plates (Nunc, Wiesbaden, Germany) for
48h. Subsequently, fresh medium and proinﬂamma-
tory stimulators were added at day 2 by carefully
replacing half of the supernatants for the following
72h, including rhIFNg (50ng/ml), rhTNFa
(20ng/ml), human soluble CD40L (500ng/ml; all
from Tebu, Offenbach, Germany), LPS from E. coli
(10mg/ml; Sigma-Aldrich, Taufkirchen, Germany)
and/or a mixture containing inactivated complete
viruses (Measles Virus, Edmonston 1mg/ml; Respiratory
Syncytial Virus (Long) 20mg/ml and Parainﬂuenza 3
(C234) 10mg/ml (all from Chemicon, Hofheim,
Germany).
Flow cytometric immunophenotyping
DC populations were characterized by labeling with
ﬂuorochrome-conjugated monoclonal Antibodies
(mAbs) and analyzed by ﬂow cytometry (FACSCali-
bure, CellQueste, Becton Dickinson, Heidelberg,
Germany). Antibodies used were: IgG1 and IgG2a
isotype control mAbs, HLA-DR (all from Becton
Dickinson, Heidelberg, Germany), CD11c (Abcam,
Cambridge, UK), CD83 and CD86 (Coulter Imuno-
tech, Hamburg, Germany).
Detection of cytokines in culture supernatants
Cell culture supernatants were collected at several
points in time from ampliﬁed HPCs (day 0), from
immature DCs after a 48h incubation period with
GM-CSF and IL-4 (day 2) and after an additional
72h incubation period with GM-CSF, IL-4 with or
without different proinﬂammatory cytokines and/or
antigen (day 5). Supernatants were stored at 2808C
until use. IL-12p40 concentration was measured by
enzyme-linked immunosorbent assay (ELISA)
according to the manufacturer’s instructions
(OptEIAe ELISA Set, Becton Dickinson, Heidel-
berg, Germany). The concentrations of IL-1b, IL-6,
IL-8, IL-10, IL-12p70 and TNFa were quantiﬁed
with the Human Inﬂammation Cytometric Bead
Array Kit (CBA, Becton Dickinson, Heidelberg,
Germany) according to the manufacturer’s
instructions.
Results
Maturation of neonatal DCs
After the ampliﬁcation period (day0), HPCs showed a
lowexpression level of the myeloid DC marker CD11c
and the costimulatory molecule CD86. Furthermore,
a moderate expression of the MHC class II HLA-DR
and the absence of the DC maturation marker CD83,
were found (Figure 1).
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48h resulted in a moderately up-regulated expression
of CD11c, whereas the expression of CD86, HLA-
DR and CD83 remained very low (day 2). This
phenotype is consistent with the reported state of
immature DCs.
In addition to GM-CSF and IL-4, immature
neonatal DCs were supplemented with proinﬂamma-
tory mediators and/or viral antigens at day 2 for a
further 72h in order to induce the maturation (day 5).
Exposure to GM-CSF and IL-4 alone, as well as
exposure to each of the proinﬂammatory mediators
and/or antigens, resulted in increased CD11c
expression of cultured cells at day 5 (Figure 1a).
Whereas the addition of single proinﬂammatory
mediators only led to small increases in the expression
of CD83, CD86 and HLA-DR, combined stimuli
induced a strong increase in marker expression at day
5 (Figure 1b–d). Especially the combination of IFNg
and LPS induced very high expression rates of CD83,
CD86 and HLA-DR in neonatal DCs, while neither
LPS nor IFNg alone were able to induce this effect.
This synergistic phenomenon was speciﬁc for the
combination of IFNg and LPS. Combinations of
IFNg with other mediators such as CD40L or TNFa
were less potent inducers of DC maturation.
Combination of LPS and IFNg with other proin-
ﬂammatory cytokines did not further increase the
expression levels of CD83, CD86 and HLA-DR
beyond the levels observed after stimulation with LPS
and IFNg (data not shown). In the presence of both
antigens and proinﬂammatory mediators, the
expression rate of CD83, CD86 and HLA-DR
exceeded those observed with proinﬂammatory
mediators alone.
Cytokine secretion of neonatal DCs
Ampliﬁed HPCs (day 0) and immature DCs (day 2)
secreted only low amounts of IL-8, IL-12p40 and
(a)
MFI
0 50 100 150 200
day 0
day 2
day 5 control
TNF
CD40L
IFN
LPS
IFNg+LPS
IFNg+CD40L
IFNg+TNFa
IFNg+CD40L+TNFa
Ag [-]
Ag [+]
(b)
(c) (d)
MFI
0 5 10 15 20
day 0
day 2
day 5 control
TNF
CD40L
IFN
LPS
IFNg+LPS
IFNg+CD40L
IFNg+TNFa
IFNg+CD40L+TNFa
MFI
0 200 400 600 800 1000 1200
day 0
day 2
day 5 control
TNF
CD40L
IFN
LPS
IFNg+LPS
IFNg+CD40L
IFNg+TNFa
IFNg+CD40L+TNFa
MFI
0 200 400 600 800 1000 1200
day 0
day 2
day 5 control
TNF
CD40L
IFN
LPS
IFNg+LPS
IFNg+CD40L
IFNg+TNFa
IFNg+CD40L+TNFa
Ag [-]
Ag [+]
CD11c CD83
HLA-DR CD86
Ag [-]
Ag [+]
Ag [-]
Ag [+]
Figure 1. Flow cytometric analysis of CD11c (a), CD83 (b), CD86 (c), HLA-DR (d). Ampliﬁed HPCs (day 0) were cultured for 2 days in
culture medium containing 10% autologous plasma, GM-CSFand IL-4 (day 2). Cells were then cultured for another 72h with GM-CSF/IL-
4 and different proinﬂammation cytokine combinations and with or without viral antigens (Measles, RSV, Parainﬂuenza)—(day 5). This is the
mean of ﬁve experiments.
Maturation of neonatal DCs 101TNFa, whereas no IL-1b, IL-6 and IL-12p70 were
detectable (Figure 2).
After prolonged incubation with GM-CSFand IL-4
for 72h, production of IL-6 and IL-8 marginally
increased, whereas the secreted amounts of IL-12p40
decreased (day 5). All other cytokine concentrations
remained virtually unchanged.
Exposure of immature neonatal DCs to either IFNg
or LPS for 72h only induced small increments in the
synthesis of IL-1b and TNFa in comparison to day 5
controls, whereas the amounts of IL-6 and IL-8
increased considerably (Figure 2). However, com-
bined stimulation with LPS and IFNg led to a marked
increase in secretion of IL-1b, IL-6, IL-8, TNFa, IL-
12p40 and IL-12p70 after 72h. Particularly note-
worthy is the production of IL-12p70 after combined
stimulation of neonatal DCs with LPS and IFNg,
since it could not be induced with any other mediator
alone or mediator combination.
DCs stimulated to mature with IFNg or combi-
nations of IFNg with CD40L and/or TNFa, revealed
no increase in IL-12p40 expression in comparison to
day 5 controls. However, the addition of viral antigens
together with IFNg or combinations with CD40L
and/or TNFa, more than doubled IL-12p40 concen-
tration (Figure 2), but did not stimulate IL-12p70
expression. Furthermore, the secretion of IL-1b and
TNFa were not increased in the presence of antigens,
independent of added stimulators (IFNg, CD40L,
TNFa or combinations of these).
Interestingly, the presence of antigens, LPS or the
combination of LPS and IFNg, induced considerable
expression of IL12p40, mostly higher than that seen
with IFNg and combinations. Combination of LPS
with other proinﬂammatory mediators showed no
additional increase in cytokine synthesis (data not
shown).
In contrast, stimulation with antigens in addition to
IFNg alone or combinations of IFNg with CD40L
and/or TNFa, initiated high cytokine production by
neonatal DCs (Figure 2). However, when IFNg and
LPS were present in cultures the addition of antigen
decreased the levels of all cytokines examined.
Very high concentrations of IL-8 were detected after
stimulation of neonatal DCs with all proinﬂammatory
mediators or their combinations tested. In contrast,
neither ampliﬁed HPCs, immature DCs nor DCs
stimulated with several proinﬂammatory mediators,
expressed IL-10 (data not shown).
Discussion
Increased susceptibility to infectious diseases in the
postnatal phase and in early infancy is a well known
clinical phenomenon. In this study, we investigated
whether the immaturity of neonatal immune
responses might be based on an impairment in the
maturation and secretory capacity of DCs by
stimulating neonatal immature DCs with various
combinations of proinﬂammatory mediators and
antigens.
Since the frequency of DCs is very low in peripheral
blood, neonatal DCs were generated in vitro from cord
blood CD34
þ HPCs. Earlier reports describe the
successful generation of DCs from HPCs in a FCS-
supplemented medium (Santiago-Schwarz et al. 1992,
Reid et al. 1992, Arrighi et al. 1999, Cella et al. 1999,
Manome et al. 1999, Gagliardi et al. 2000). However,
this approach involves the risk of an accidental
exposure to foreign antigens and/or mediators and
could therefore facilitate the activation of DCs. DCs
grown in a medium containing FCS showan increased
secretion of IL-12 in comparison to those generated in
a medium supplemented with autologous plasma
(Ebner et al. 2001). To minimize these unspeciﬁc side
effects, we modiﬁed the protocol described by Arrighi
et al. (1999) for the generation of HPC-derived DCs.
Instead of FCS we used human AB-serum and
autologous plasma, respectively, during the ampliﬁca-
tion period and during differentiation into DCs. The
use of both AB-serum and autologous plasma was
necessary because the cord blood samples did not
contain sufﬁcient amount of autologous plasma for
the whole culture period.
The induction of protective cell-mediated immunity
requires an efﬁcient maturation of DCs. In vivo,
immature DCs at the site of infection are exposed to
many different proinﬂammatory mediators, which
may inﬂuence the maturation of DCs. Therefore a
main target of this study was to determine the effect of
different proinﬂammatory mediators and microbial
antigens on the maturation of neonatal DCs in vitro.A
combination of antigens from three viral pathogens
(RSV, PIV, MV) were selected according to their
outstanding importance during infancy.
Even though each of the proinﬂammatory stimuli
used in this study have previously been described as
efﬁcient signals for the maturation of adult DCs
(Santiago-Schwarz et al. 1992, Arrighi et al. 1999,
Vieira et al. 2000, Kalinski et al. 2001, de Jong et al.
2002), our results show that exposure to a single
proinﬂammatory mediator is a poor stimulus to
induce maturation of neonatal DCs. These obser-
vations point towards a lower responsiveness of
neonatal DCs to single proinﬂammatory mediators
in comparison to adult DCs.
Cytokine production by DCs plays an important
role in the course of immune responses (de Saint-Vis
et al. 1998). In our experiments all mediators
induced the production of IL-6 und IL-8 in neonatal
DCs. The addition of LPS with or without IFNg
supplementary, increased IL-6 synthesis in compari-
son to other mediators or their combinations. TNFa,
IL-6 and IL-8 are known to play important roles in
inﬂammatory processes and also support speciﬁc
immune responses. IL-6 is a potent growth and
D. Krumbiegel et al. 102differentiation factor for B cells that participates in
the development of CTL responses and enhances the
survival of naı ¨ve T cells (Verhasselt et al. 1997,
Teague et al. 2000). IL-8 supports the survival of
hematopoietic cells (Han et al. 1997). TNFa
production has been described in many types of
DCs (Larrick et al. 1989, Caux et al. 1994, Verhasselt
et al. 1997). It enhances the survival of hematopoietic
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Figure 2. Cytokine expression measured by IL-12p40 ELISA and CBA. Cells were cultured as described before, supernatants were taken
after HPC ampliﬁcation (day 0), from immature DCs (day 2) and from mature DCs (day 5) and frozen at 2808C. This is the mean of four
experiments.
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(Morrison et al. 2003). This explains the large
number of DCs under inﬂammatory conditions,
where local concentrations of TNFa are high. In our
experiments we showed that HPC-derived neonatal
DCs are also able to produce TNFa, but only after
combined stimulation with LPS and IFNg.
Cell-mediated immune responses to intracellular
pathogens are promoted by Th1 effector cells,
which are characterized by their production of
IFNg. However, IFNg itself is not sufﬁcient for the
development of a Th1 immune response. The
dominant factor for the development of Th1
immune responses is thought to be the secretion
of IL-12 by DCs (Trinchieri 1994). While reports
suggest that neonatal and adult PBMCs synthesize
equivalent amounts of IL-12p40 in response to
microbial stimuli (Scott et al. 1997), the secretion
of bioactive IL-12p70 by cord blood cells is
generally demonstrated to be limited (Lee et al.
1996, Joyner et al. 2000, Goriely et al. 2001, Tonon
et al. 2002, Langrish et al. 2002). We observed that
only DCs matured with LPS with or without IFNg,
but no other proinﬂammatory mediator or their
combinations, profoundly increased IL-12p40 pro-
duction in comparison to day 5 controls. Whereas
antigen addition doubled IL-12p40 secretion, it did
not increase but dampened IL-12p70 synthesis,
drawing the conclusion that the antigen combi-
nation used selectively activates IL-12p40 gene
expression. Upon maturation, neonatal DCs have
been shown to be characterized by a defect in IL-
12p35 gene expression in comparison to adult DCs.
This limited production of IL-12p35 has been
described as being stimuli-independent (CD40L,
LPS, Poly (I:C), IFNg), which could however, be
overcome by the combination of LPS and IFNg
( G o r i e l ye ta l .2 0 0 1 ) .A d u l tD C sh a v eb e e n
described to produce IL-12p70 after stimulation
with LPS alone, but not with TNFa or IFNg (Cella
et al. 1999). Interestingly, the addition of IFNg,
with or without TNFa, induced an increase in the
expression of maturation and costimulatory surface
molecules without induction of IL-12p70 pro-
duction. This observation suggests that phenotypi-
cally mature DCs do not necessarily synthesize
IL-12p70.
During the maturation of DCs, a decreased
viability after stimulation with several proinﬂamma-
tory substances was observed by ﬂow cytometry (data
not shown). Since proinﬂammatory mediators and
antigens also induced DC maturation, it could be
suspected that maturation of DCs increases their
susceptibility to apoptosis. A question arising from
these observations is whether the maturation of
neonatal DCs may be inﬂuenced by the exposure to
mediators released by apoptotic and/or necrotic cells.
However, at least after addition of supernatants
of apoptotic and/or necrotic autologous cells to
immature DCs, the expression pattern of CD11c,
CD86, CD83 and HLA-DR did not show any signs
of changes in DC maturation status (data not
shown).
In conclusion, the combination of proinﬂammatory
mediators was far more efﬁcient in inducing the
maturation and cytokine secretion of neonatal DCs in
comparison to single proinﬂammatory agents. The
synergistic effect of combinations of proinﬂammatory
mediators on the maturational state of neonatal DCs
could best be exempliﬁed by the use of IFNg and LPS.
The combined stimulation of immature neonatal DCs
with IFNg and LPS efﬁciently induced high
expression rates of maturation and costimulatory
markers as well as production of proinﬂammatory
cytokines. These ﬁndings indicate a critical import-
ance for combined signaling of microbial and
proinﬂammatory mediators in the maturational
process of neonatal DCs. Furthermore, they suggest
a high activation threshold of neonatal DCs, which
could contribute to the clinical observation of an
increased susceptibility to infectious diseases.
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